CI
FOLD

Cowen Inc’s Amicus Therapeutics FOLD Stock Holding History

Cowen Inc’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-12,353
Closed -$151K – 410
2018
Q4 		$118K Buy
12,353
+6,653
+117% +$73.1K 0.01% 247
2018
Q3 		$69K Sell
5,700
-18,800
-77% -$263K 0.01% 324
2018
Q2 		$383 Buy
+24,500
New +$370K 0.02% 284
2017
Q4 		– Sell
-147,000
Closed -$2.22M – 311
2017
Q3 		$2.22M Buy
147,000
+118,000
+407% +$1.56M 0.08% 87
2017
Q2 		$292K Buy
29,000
+8,000
+38% +$64.4K 0.02% 247
2017
Q1 		$150K Buy
+21,000
New +$133K 0.01% 212
2016
Q1 		– Sell
-15,500
Closed -$110K – 291
2015
Q4 		$150K Buy
+15,500
New +$140K 0.01% 270

Other funds holding FOLD

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Cowen Inc's FOLD Position: Q1 2019 in Review

Cowen Inc sold out of Amicus Therapeutics (FOLD) in Q1 2019, closing a stake of 12,353 shares — an estimated $151K sold.

Cowen Inc first reported a position in FOLD in Q4 2015 and held it in 7 quarters. The position peaked at $2.22M in Q3 2017. 205 funds tracked by Wall St. Rank hold FOLD as of Q1 2019.

  • Cowen Inc reported no remaining Amicus Therapeutics position as of Q1 2019 after selling out during the quarter.
  • Cowen Inc sold 12,353 Amicus Therapeutics shares in Q1 2019, an estimated $151K.
  • Cowen Inc first reported a position in Amicus Therapeutics in Q4 2015 and held it in 7 quarters.
  • Cowen Inc's Amicus Therapeutics position peaked at $2.22M in Q3 2017.
  • 205 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2019.

Based on Cowen Inc's 13F filing for Q1 2019, filed 14 May 2019.